COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ news
6/19 Late treatment study
NIH, study not available yet (News) (not included in the study count)
NIH halts clinical trial of hydroxychloroquine
Source   PDF   Share   Tweet
NIH halts late stage trial reporting no harm and no benefit. 470 patients.

NIH et al., 6/19/2020, preprint, 1 author.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.